NPI registry status
Active
2026 NPPES data Hematology (Internal Medicine) Physician NPI 1740697192 M.D.
Verify on CMS → Faiza Manji, M.D.
Hematology (Internal Medicine) Physician in Brandon, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,483 in Hematology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
419
Medicare Part D claims · 102 beneficiaries · Hematology (Internal Medicine) Physician avg: 684
Generic prescribing
72%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.4K
108 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Faiza Manji, M.D. filed 419 Medicare Part D claims in 2024 as a Hematology (Internal Medicine) Physician in Brandon, Florida, prescribing 72% generic.
- 419
- Part D claims, 2024
- 72%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Faiza Manji, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1740697192), first enumerated 07/17/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 419 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.4K in reported industry payments (108 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Faiza Manji, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1740697192 · Hematology (Internal Medicine) Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1740697192
- ENUM-MID 2014
- TAX-NARROW 1,483
- RX-LIGHT 419
- BOOK-THIN 202 in Florida
- PHOTO-ENUM Megan Jagosky, MD · 2014
Faiza Manji, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
419 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Faiza Manji, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Faiza Manji, M.D.?
Quality data not reportedPrimary specialty
Hematology (Internal Medicine) Physician
Medicare Part D claims
419 39% vs specialty avg
Specialty distribution in Florida
How Hematology (Internal Medicine) Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1740697192 |
|---|---|
| Specialty | Hematology (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/17/2014 |
Hospital and facility affiliations
Facilities where Faiza Manji, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Florida Cancer Specialists And Research Institute, LLC
Sun City Center, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Faiza Manji, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.4K
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Faiza Manji, M.D.. To verify Faiza Manji, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Faiza Manji, M.D. - brand share 28.0%
Hematology (Internal Medicine) Physician average
28% brand-name claims vs 72% generic, on 419 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
419
Total Claims
$667K
Total Drug Cost
102
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 548.1
- Total Day Supply
- 14,429
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $654K
- Generic Drug Cost
- $13K
- Opioid Claims
- 26 (6.2% rate)
Patient Demographics
- Average Patient Age
- 77.4 years
- Avg HCC Risk Score
- 2.31
- Gender Split
- 51% female / 49% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Faiza Manji, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Eliquis
Eliquis
32 claims
- Ondansetron Odt
Ondansetron Odt
31 claims
- Anastrozole
Anastrozole
25 claims
- Hydroxyurea
Hydroxyurea
25 claims
- Prednisone
Prednisone
24 claims
- Venclexta
Venclexta
21 claims
- Prochlorperazine M…
Prochlorperazine Maleate
20 claims
- Letrozole
Letrozole
18 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 32 |
| Ondansetron Odt Ondansetron | 31 |
| Anastrozole | 25 |
| Hydroxyurea | 25 |
| Prednisone | 24 |
| Venclexta Venetoclax | 21 |
| Prochlorperazine Maleate | 20 |
| Letrozole | 18 |
| Xarelto Rivaroxaban | 18 |
| Brukinsa Zanubrutinib | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology (Internal Medicine) Physician in FL →
All providers in Florida →
Compare specialties →
Hematology (Internal Medicine) Physician Overview
How Faiza Manji, M.D. fits within the Hematology (Internal Medicine) Physician landscape nationally.
1,483
Hematology (Internal Medicine) Physician Providers in US
50
States with Hematology (Internal Medicine) Physician
684
Avg Claims per Provider
Faiza Manji, M.D.'s 419 claims are below the specialty average of 684.
Nationwide Hematology (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Manji, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology (Internal Medicine) Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Manji.
One of 202 Hematology (Internal Medicine) Physician providers enrolled in Florida, 5 are shown here.
Dr. Yeon Ahn
MD
Miami, FL
Dr. Vaseem Akhtar
M.D.
Okeechobee, FL
Dr. Geethanjali Akula
M.D.
Orlando, FL
Dr. Jose Alemar
MD
Clearwater, FL
Dr. Christopher Alexander
DO
Ormond Beach, FL
Compare Hematology (Internal Medicine) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Faiza Manji, M.D.'s specialty? ▼
Faiza Manji, M.D. specializes in Hematology (Internal Medicine) Physician and practices in Brandon, Florida. Credentials: M.D..
How much does Faiza Manji, M.D. prescribe under Medicare Part D? ▼
In 2024, Faiza Manji, M.D. wrote 419 Medicare Part D claims totaling $667K in drug costs for 102 beneficiaries.
Where is Faiza Manji, M.D. located? ▼
Faiza Manji, M.D. is located at 403 S KINGS AVE STE 100, Brandon, FL, 33511. Phone: (813) 982-3460.
What is Faiza Manji, M.D.'s NPI number? ▼
Faiza Manji, M.D.'s National Provider Identifier (NPI) is 1740697192, issued on 07/17/2014.
Does Faiza Manji, M.D. prescribe more brand-name or generic drugs? ▼
Faiza Manji, M.D.'s prescribing is 28% brand-name and 72% generic drugs by claim count, with $654K in brand drug costs.
Does Faiza Manji, M.D. prescribe opioids? ▼
Yes, Faiza Manji, M.D. had 26 opioid claims in 2024 with an opioid prescribing rate of 6.2%.
How many Hematology (Internal Medicine) Physician providers are there in the US? ▼
There are 1,483 Hematology (Internal Medicine) Physician providers across 50 states in the US. The average Hematology (Internal Medicine) Physician provider writes 684 Medicare Part D claims per year.
What drugs does Faiza Manji, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Faiza Manji, M.D.'s most frequently prescribed drugs include Eliquis, Ondansetron Odt, Anastrozole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Faiza Manji, M.D. accept Medicare? ▼
Faiza Manji, M.D. appears in CMS Medicare data with 419 Part D claims and 102 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Faiza Manji, M.D.'s credentials? ▼
Faiza Manji, M.D.'s NPI is 1740697192 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.